|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Mar 1986 |
|
MechanismH2 receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date16 Aug 1977 |
|
MechanismCYP51A1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date30 Jan 1974 |
100 Clinical Results associated with Medtech Products, Inc.
0 Patents (Medical) associated with Medtech Products, Inc.
100 Deals associated with Medtech Products, Inc.
100 Translational Medicine associated with Medtech Products, Inc.